Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects
Acta Pediatrica Feb 14, 2018
Balachandran B, et al. - Researchers intended to compare using early oral diazoxide or a placebo for small for gestational age (SGA) neonates with hyperinsulinaemic hypoglycaemia (HH). With no apparent adverse effects, using oral diazoxide for SGA neonates with HH provided early hypoglycaemic control.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
